- Author:
- pmr2.import <nobody@models.cellml.org>
- Date:
- 2007-08-02 02:18:25+12:00
- Desc:
- committing version02 of kirschner_panetta_1998
- Permanent Source URI:
- https://models.physiomeproject.org/workspace/kirschner_panetta_1998/rawfile/d99bda8c0f6e02c664153c61be2e446dcb55ee26/kirschner_panetta_1998.cellml
<?xml version='1.0' encoding='utf-8'?>
<!-- FILE : kirschner_model_1998.xml
CREATED : 28th March 2004
LAST MODIFIED : 28th March 2004
AUTHOR : Catherine Lloyd
Bioengineering Institute
The University of Auckland
MODEL STATUS : This model conforms to the CellML 1.0 Specification released on
10th August 2001, and the 16/1/02 CellML Metadata 1.0 Specification.
DESCRIPTION : This file contains a CellML description of Kirschner and Panetta's 1998 mathematical model of the immunotherapy of the tumour-immune interaction.
CHANGES:
--><model xmlns="http://www.cellml.org/cellml/1.0#" xmlns:cmeta="http://www.cellml.org/metadata/1.0#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bqs="http://www.cellml.org/bqs/1.0#" xmlns:cellml="http://www.cellml.org/cellml/1.0#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:vCard="http://www.w3.org/2001/vcard-rdf/3.0#" xmlns:ns7="http://www.cellml.org/metadata/simulation/1.0#" name="kirschner_panetta_1998_version01" cmeta:id="kirschner_panetta_1998_version01">
<documentation xmlns="http://cellml.org/tmp-documentation">
<article>
<articleinfo>
<title>Modelling Immunotherapy of the Tumour-Immune Interaction</title>
<author>
<firstname>Catherine</firstname>
<surname>Lloyd</surname>
<affiliation>
<shortaffil>Bioengineering Institute, University of Auckland</shortaffil>
</affiliation>
</author>
</articleinfo>
<section id="sec_status">
<title>Model Status</title>
<para>
This is the original unchecked version of the model imported from the previous
CellML model repository, 24-Jan-2006.
</para>
</section>
<sect1 id="sec_structure">
<title>Model Structure</title>
<para>
Cancer is one of the leading causes of death in the world, yet little is understood about the mechanisms which underlie its establishment and destruction. While surgery and/or chemo- and radiotherapy are an important part of treating cancer, they do not represent an 100% effective cure, and often patients will experience a relapse. There is a great motivation to find preventative measures and more effective treatment strategies for cancer, and efforts are being channeled into immunotherapy. Immunotherapy refers to the use of cytokines in the treatment of cancer.
</para>
<para>
Cytokines are protein hormones that mediate both natural and specific immunity. They are mainly produced by activated T lymphocytes during cellular mediated immune responses. Interleukin-2 (IL-2) is the main cytokine responsible for lymphocyte activation, growth, and differnetiation. It is produced by CD4<superscript>+</superscript> (or helper) T cells and to a lesser extent, by CD8<superscript>+</superscript> (or cytotoxic) T cells. Because IL-2 acts on the same cells that produce it, it is referred to as an autocrine growth factor, although it can also act on nearby T cells, making it a paracrine growth factor. In clinical trials, IL-2 has been shown to enhance CD8<superscript>+</superscript> T cell activity at different disease stages. Also, natural killer (NK) cell activity is restored and CD4<superscript>+</superscript> and CD8<superscript>+</superscript> T cell populations expand.
</para>
<para>
Adoptive cellular immunotherapy (ACI) refers to the injection of cultured immune cells that have anti-tumour activity into a patient with a tumour. Large amounts of IL-2 are also introduced in one of two ways:
</para>
<itemizedlist>
<listitem>
<para>1) <emphasis>LAK-(lymphocyte-activated killer cell) therapy</emphasis> - These cells are derived from <emphasis>in vitro</emphasis> culturing with high concentrations of IL-2 of peripheral blood leukocytes removed from patients with tumours. The LAKs are then injected back into the patient at the cancer site. These cells are mainly thaought to be NK cells.</para>
</listitem>
<listitem>
<para>2) <emphasis>TIL-(tumour infiltrating lymphocyte) therapy</emphasis> - These cells are derived from lymphocytes recovered from the patient's tumours. They are then incubated with high concentrations of IL-2 <emphasis>in vitro</emphasis> and are comprised of activated NK cells and CD8<superscript>+</superscript> T cells. They are then injected back into the patient at the tumour site.</para>
</listitem>
</itemizedlist>
<para>
Kirschner and Panetta use ideas from pre-existing mathematical models of tumour-immune dymanics and combine them in the simple model shown in <xref linkend="fig_reaction_diagram"/> below. They define three populations:
</para>
<itemizedlist>
<listitem>
<para>1) the activated immune system cells, which include CD8<superscript>+</superscript> T cells, macrophages and NK cells, and are called effector cells;</para>
</listitem> <listitem>
<para>2) the tumour cells; and</para>
</listitem>
<listitem>
<para>3) the concentration of IL-2.</para>
</listitem>
</itemizedlist>
<para>
The mathematical model describes the interactions between the effector cells, tumour cells and the cytokine IL-2.
</para>
<para>
The model has been described here in CellML (the raw CellML description of the Kirscher and Panetta 1998 model can be downloaded in various formats as described in <xref linkend="sec_download_this_model"/>).
</para>
<para>
The complete original paper reference is cited below:
</para>
<para>
<ulink url="http://springerlink.metapress.com/app/home/contribution.asp?wasp=e2eygx3dwg4rugc1bmeg&referrer=parent&backto=issue,2,4;journal,72,93;linkingpublicationresults,1:100436,1">Modeling immunotherapy of the tumor - immune interaction</ulink>, Denise Kirschner and John Carl Panetta, 1998, <ulink url="http://springerlink.metapress.com/app/home/journal.asp?wasp=2falymyvrgckmeuhugdh&referrer=backto&backto=linkingpublicationresults,1:100436,1;&absoluteposition=72#A72">
<emphasis>Journal of Mathematical Biology</emphasis>
</ulink>, 37, 235-252. (A PDF version of the article is available to subscribers on the <emphasis>Journal of Mathematical Biology</emphasis> website.) <ulink url="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9785481&dopt=Abstract">PubMed ID: 9785481</ulink>
</para>
<informalfigure float="0" id="fig_reaction_diagram">
<mediaobject>
<imageobject>
<objectinfo>
<title>reaction diagram</title>
</objectinfo>
<imagedata fileref="kirschner_1998.png"/>
</imageobject>
<caption>
A schematic diagram of the interactions between the effector T cells, the tumour cells, and the cytokine interleukin-2 (IL-2).
</caption>
</mediaobject>
</informalfigure>
</sect1>
</article>
</documentation>
<units name="day">
<unit units="second" multiplier="86400.0"/>
</units>
<units name="first_order_rate_constant">
<unit units="day" exponent="-1"/>
</units>
<units base_units="yes" name="cells"/>
<units name="cells_per_microlitre">
<unit units="cells"/>
<unit units="litre" prefix="micro" exponent="-1"/>
</units>
<units name="flux">
<unit units="cells"/>
<unit units="litre" prefix="micro" exponent="-1"/>
<unit units="day" exponent="-1"/>
</units>
<units name="micromolar">
<unit units="mole" prefix="micro"/>
<unit units="litre" exponent="-1"/>
</units>
<component name="environment">
<variable units="day" public_interface="out" name="time"/>
</component>
<component name="E" cmeta:id="E">
<rdf:RDF>
<rdf:Description rdf:about="E">
<dc:title>E</dc:title>
<dcterms:alternative>effector T cells</dcterms:alternative>
</rdf:Description>
</rdf:RDF>
<variable units="cells_per_microlitre" public_interface="out" name="E"/>
<variable units="first_order_rate_constant" name="mu2" initial_value="0.03"/>
<variable units="first_order_rate_constant" name="c" initial_value="0.01"/>
<variable units="first_order_rate_constant" name="p1" initial_value="0.1245"/>
<variable units="cells_per_microlitre" name="g1" initial_value="2.0E-7"/>
<variable units="flux" name="s1" initial_value="1"/>
<variable units="micromolar" public_interface="in" name="IL"/>
<variable units="cells_per_microlitre" public_interface="in" name="T"/>
<variable units="day" public_interface="in" name="time"/>
<math xmlns="http://www.w3.org/1998/Math/MathML">
<apply>
<eq/>
<apply>
<diff/>
<bvar>
<ci>time</ci>
</bvar>
<ci>E</ci>
</apply>
<apply>
<plus/>
<apply>
<minus/>
<apply>
<times/>
<ci> c </ci>
<ci> T </ci>
</apply>
<apply>
<times/>
<ci> mu2 </ci>
<ci> E </ci>
</apply>
</apply>
<apply>
<divide/>
<apply>
<times/>
<ci> p1 </ci>
<ci> E </ci>
<ci> IL </ci>
</apply>
<apply>
<plus/>
<ci> g1 </ci>
<ci> IL </ci>
</apply>
</apply>
<ci> s1 </ci>
</apply>
</apply>
</math>
</component>
<component name="T" cmeta:id="T">
<rdf:RDF>
<rdf:Description rdf:about="T">
<dc:title>T</dc:title>
<dcterms:alternative>tumour cells</dcterms:alternative>
</rdf:Description>
</rdf:RDF>
<variable units="cells_per_microlitre" public_interface="out" name="T"/>
<variable units="first_order_rate_constant" name="r2" initial_value="0.18"/>
<variable units="flux" name="r2_T"/>
<variable units="first_order_rate_constant" name="a" initial_value="1.0"/>
<variable units="first_order_rate_constant" name="b" initial_value="1.0E-9"/>
<variable units="cells_per_microlitre" name="g2" initial_value="1.0E5"/>
<variable units="cells_per_microlitre" public_interface="in" name="E"/>
<variable units="day" public_interface="in" name="time"/>
<math xmlns="http://www.w3.org/1998/Math/MathML">
<apply>
<eq/>
<apply>
<diff/>
<bvar>
<ci>time</ci>
</bvar>
<ci>T</ci>
</apply>
<apply>
<minus/>
<apply>
<times/>
<ci> r2_T </ci>
<ci> T </ci>
</apply>
<apply>
<divide/>
<apply>
<times/>
<ci> a </ci>
<ci> E </ci>
<ci> T </ci>
</apply>
<apply>
<plus/>
<ci> g2 </ci>
<ci> T </ci>
</apply>
</apply>
</apply>
</apply>
<apply id="r2_T_calculation">
<eq/>
<ci> r2_T </ci>
<apply>
<times/>
<ci> r2 </ci>
<apply>
<minus/>
<cn cellml:units="dimensionless"> 1.0 </cn>
<apply>
<times/>
<ci> b </ci>
<ci> T </ci>
</apply>
</apply>
</apply>
</apply>
</math>
</component>
<component name="IL" cmeta:id="IL">
<rdf:RDF>
<rdf:Description rdf:about="IL">
<dc:title>IL</dc:title>
<dcterms:alternative>concentration of the cytokine IL-2 in the single tumour-site compartment</dcterms:alternative>
</rdf:Description>
</rdf:RDF>
<variable units="micromolar" public_interface="out" name="IL"/>
<variable units="first_order_rate_constant" name="mu3" initial_value="10.0"/>
<variable units="first_order_rate_constant" name="p2" initial_value="5.0"/>
<variable units="cells_per_microlitre" name="g3" initial_value="1.0E3"/>
<variable units="flux" name="s2" initial_value="0.1"/>
<variable units="cells_per_microlitre" public_interface="in" name="E"/>
<variable units="cells_per_microlitre" public_interface="in" name="T"/>
<variable units="day" public_interface="in" name="time"/>
<math xmlns="http://www.w3.org/1998/Math/MathML">
<apply>
<eq/>
<apply>
<diff/>
<bvar>
<ci>time</ci>
</bvar>
<ci>IL</ci>
</apply>
<apply>
<plus/>
<apply>
<minus/>
<apply>
<divide/>
<apply>
<times/>
<ci> p2 </ci>
<ci> E </ci>
<ci> T </ci>
</apply>
<apply>
<plus/>
<ci> g3 </ci>
<ci> T </ci>
</apply>
</apply>
<apply>
<times/>
<ci> mu3 </ci>
<ci> IL </ci>
</apply>
</apply>
<ci> s2 </ci>
</apply>
</apply>
</math>
</component>
<connection>
<map_components component_2="environment" component_1="E"/>
<map_variables variable_2="time" variable_1="time"/>
</connection>
<connection>
<map_components component_2="environment" component_1="T"/>
<map_variables variable_2="time" variable_1="time"/>
</connection>
<connection>
<map_components component_2="environment" component_1="IL"/>
<map_variables variable_2="time" variable_1="time"/>
</connection>
<connection>
<map_components component_2="T" component_1="E"/>
<map_variables variable_2="T" variable_1="T"/>
<map_variables variable_2="E" variable_1="E"/>
</connection>
<connection>
<map_components component_2="IL" component_1="E"/>
<map_variables variable_2="IL" variable_1="IL"/>
<map_variables variable_2="E" variable_1="E"/>
</connection>
<connection>
<map_components component_2="T" component_1="IL"/>
<map_variables variable_2="T" variable_1="T"/>
</connection>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
<rdf:Bag rdf:about="rdf:#a6341a62-d49f-4c5e-b052-b471cda300fe">
<rdf:li>immunology</rdf:li>
<rdf:li>T cell</rdf:li>
<rdf:li>tumour</rdf:li>
<rdf:li>cytokine</rdf:li>
</rdf:Bag>
<rdf:Description rdf:about="rdf:#a6341a62-d49f-4c5e-b052-b471cda300fe"/>
<rdf:Seq rdf:about="rdf:#317bab89-93db-4255-bbab-be23a3f91e6a">
<rdf:li rdf:resource="rdf:#2eee4bfa-4ac2-401f-8911-759bf9b8a2e2"/>
<rdf:li rdf:resource="rdf:#d235f679-f01d-4109-9440-2951f4be2ef2"/>
</rdf:Seq>
<rdf:Description rdf:about="rdf:#b6b39fdd-0d54-4a64-a78c-be43604b6763">
<vCard:Given>John</vCard:Given>
<vCard:Family>Panetta</vCard:Family>
<vCard:Other>Carl</vCard:Other>
</rdf:Description>
<rdf:Description rdf:about="rdf:#97f05fc8-5dff-4057-b46e-95a3d7939ecf">
<dcterms:W3CDTF>1998-09</dcterms:W3CDTF>
</rdf:Description>
<rdf:Description rdf:about="rdf:#7c6a9638-372d-4191-b362-847260b56871">
<dcterms:W3CDTF>2007-08-02T14:17:42+12:00</dcterms:W3CDTF>
</rdf:Description>
<rdf:Description rdf:about="rdf:#25d96e71-6924-4755-aa10-89d594c8be58">
<vCard:ORG rdf:resource="rdf:#35ab8db3-106f-4b23-b013-6414fb173e6a"/>
<vCard:EMAIL rdf:resource="rdf:#ef8a43d2-50b0-42f3-bda1-68ddec97ccc7"/>
<vCard:N rdf:resource="rdf:#c159b38b-510d-4e47-835a-7eb0b1aa3684"/>
</rdf:Description>
<rdf:Description rdf:about="rdf:#97e17be0-1939-4e3e-ba09-1107af37b61f">
<bqs:Pubmed_id>9785481</bqs:Pubmed_id>
<bqs:JournalArticle rdf:resource="rdf:#16d971b4-a6d7-407f-8adb-63285b86c293"/>
</rdf:Description>
<rdf:Description rdf:about="rdf:#$l+h6c">
<ns7:boundIntervals rdf:resource="rdf:#$m+h6c"/>
</rdf:Description>
<rdf:Description rdf:about="rdf:#ef8a43d2-50b0-42f3-bda1-68ddec97ccc7">
<rdf:type rdf:resource="http://imc.org/vCard/3.0#internet"/>
<rdf:value>c.lloyd@auckland.ac.nz</rdf:value>
</rdf:Description>
<rdf:Description rdf:about="rdf:#3649cadb-1733-41d3-babc-4cb88ab82afd">
<dc:subject rdf:resource="rdf:#c3d38c25-413b-4dfc-827a-3999dcce4143"/>
</rdf:Description>
<rdf:Description rdf:about="rdf:#9bf3649e-8cc7-4f8b-b5ea-cc542019938a">
<dcterms:modified rdf:resource="rdf:#7c6a9638-372d-4191-b362-847260b56871"/>
<rdf:value>Values of 1.0 and 0.1 have been used for the variables s1 and s2, respectively, which allows this model to run. s1 is a treatment term that represents an external source of effector cells such as LAK or TIL cells. s2 is a treatment term that represents an input of IL2 into the system. The values for these variables are not given in the paper but those given here appear to be reasonable.</rdf:value>
<cmeta:modifier rdf:resource="rdf:#88f4a598-80a7-45d2-b1b1-3b058e01e91a"/>
</rdf:Description>
<rdf:Description rdf:about="rdf:#16d971b4-a6d7-407f-8adb-63285b86c293">
<dc:creator rdf:resource="rdf:#317bab89-93db-4255-bbab-be23a3f91e6a"/>
<dc:title>Modeling immunotherapy of the tumor-immune interaction</dc:title>
<bqs:volume>37</bqs:volume>
<bqs:first_page>235</bqs:first_page>
<bqs:Journal rdf:resource="rdf:#92691d85-bb27-4c00-a1eb-85a44bd9fe14"/>
<dcterms:issued rdf:resource="rdf:#97f05fc8-5dff-4057-b46e-95a3d7939ecf"/>
<bqs:last_page>252</bqs:last_page>
</rdf:Description>
<rdf:Description rdf:about="rdf:#35ab8db3-106f-4b23-b013-6414fb173e6a">
<vCard:Orgname>The University of Auckland</vCard:Orgname>
<vCard:Orgunit>The Bioengineering Institute</vCard:Orgunit>
</rdf:Description>
<rdf:Description rdf:about="rdf:#92691d85-bb27-4c00-a1eb-85a44bd9fe14">
<dc:title>Journal of Mathematical Biology</dc:title>
</rdf:Description>
<rdf:Description rdf:about="rdf:#50d2ede6-1ddf-4604-8420-8d452a5c41bc">
<vCard:FN>Catherine Lloyd</vCard:FN>
</rdf:Description>
<rdf:Description rdf:about="rdf:#05c49352-3cb7-4b1c-bf62-63cf75955245">
<dc:creator rdf:resource="rdf:#ae45a477-b834-4fbe-a892-5cd5f97c8f2f"/>
<rdf:value>Values of 1.0 and 0.1 have been used for the variables s1 and s2, respectively, which allows this model to run. s1 is a treatment term that represents an external source of effector cells such as LAK or TIL cells. s2 is a treatment term that represents an input of IL2 into the system. The values for these variables are not given in the paper but those given here appear to be reasonable. This model runs in PCEnv, but does not produce the output shown in the paper.</rdf:value>
</rdf:Description>
<rdf:Description rdf:about="rdf:#57743721-d471-4520-8b80-77dec871ac34">
<vCard:Given>James</vCard:Given>
<vCard:Family>Lawson</vCard:Family>
<vCard:Other>Richard</vCard:Other>
</rdf:Description>
<rdf:Description rdf:about="rdf:#88f4a598-80a7-45d2-b1b1-3b058e01e91a">
<vCard:N rdf:resource="rdf:#57743721-d471-4520-8b80-77dec871ac34"/>
</rdf:Description>
<rdf:Description rdf:about="rdf:#5dd68ddc-7d24-46e2-8ad8-f7bf7f165bd2">
<dc:creator rdf:resource="rdf:#50d2ede6-1ddf-4604-8420-8d452a5c41bc"/>
<rdf:value>This is the CellML description of Kirschner and Panetta's 1998 mathematical model of the immunotherapy of the tumour-immune interaction.</rdf:value>
</rdf:Description>
<rdf:Description rdf:about="rdf:#ae45a477-b834-4fbe-a892-5cd5f97c8f2f">
<vCard:FN>James Lawson</vCard:FN>
</rdf:Description>
<rdf:Description rdf:about="rdf:#2eee4bfa-4ac2-401f-8911-759bf9b8a2e2">
<rdf:type rdf:resource="http://www.cellml.org/bqs/1.0#Person"/>
<vCard:N rdf:resource="rdf:#57c3c87c-3c69-4080-bad1-99e33f2eb5f1"/>
</rdf:Description>
<rdf:Description rdf:about="rdf:#$m+h6c">
<rdf:rest rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#nil"/>
<rdf:first rdf:resource="rdf:#$n+h6c"/>
</rdf:Description>
<rdf:Description rdf:about="rdf:#c3d38c25-413b-4dfc-827a-3999dcce4143">
<bqs:subject_type>keyword</bqs:subject_type>
<rdf:value rdf:resource="rdf:#a6341a62-d49f-4c5e-b052-b471cda300fe"/>
</rdf:Description>
<rdf:Description rdf:about="#kirschner_panetta_1998_version01">
<ns7:simulation rdf:resource="rdf:#$l+h6c"/>
<dc:title>Kirschner and Panetta's 1998 mathematical model of the immunotherapy of the tumour-immune interaction.</dc:title>
<cmeta:bio_entity>T lymphocyte</cmeta:bio_entity>
<cmeta:comment rdf:resource="rdf:#5dd68ddc-7d24-46e2-8ad8-f7bf7f165bd2"/>
<bqs:reference rdf:resource="rdf:#3649cadb-1733-41d3-babc-4cb88ab82afd"/>
<bqs:reference rdf:resource="rdf:#97e17be0-1939-4e3e-ba09-1107af37b61f"/>
</rdf:Description>
<rdf:Description rdf:about="">
<dc:publisher>The University of Auckland, Bioengineering Institute</dc:publisher>
<cmeta:comment rdf:resource="rdf:#05c49352-3cb7-4b1c-bf62-63cf75955245"/>
<dcterms:created rdf:resource="rdf:#a968a3dd-3d5a-4fba-9a9d-e3cf997e8c67"/>
<dc:creator rdf:resource="rdf:#25d96e71-6924-4755-aa10-89d594c8be58"/>
<cmeta:modification rdf:resource="rdf:#9bf3649e-8cc7-4f8b-b5ea-cc542019938a"/>
</rdf:Description>
<rdf:Description rdf:about="rdf:#57c3c87c-3c69-4080-bad1-99e33f2eb5f1">
<vCard:Given>Denise</vCard:Given>
<vCard:Family>Kirschner</vCard:Family>
</rdf:Description>
<rdf:Description rdf:about="rdf:#d235f679-f01d-4109-9440-2951f4be2ef2">
<rdf:type rdf:resource="http://www.cellml.org/bqs/1.0#Person"/>
<vCard:N rdf:resource="rdf:#b6b39fdd-0d54-4a64-a78c-be43604b6763"/>
</rdf:Description>
<rdf:Description rdf:about="rdf:#c159b38b-510d-4e47-835a-7eb0b1aa3684">
<vCard:Given>Catherine</vCard:Given>
<vCard:Family>Lloyd</vCard:Family>
<vCard:Other>May</vCard:Other>
</rdf:Description>
<rdf:Description rdf:about="rdf:#$n+h6c">
<ns7:endingValue>5000</ns7:endingValue>
<ns7:nonstandard-pointDensity>100000</ns7:nonstandard-pointDensity>
<ns7:maximumStepSize>0.001</ns7:maximumStepSize>
</rdf:Description>
<rdf:Description rdf:about="rdf:#a968a3dd-3d5a-4fba-9a9d-e3cf997e8c67">
<dcterms:W3CDTF>2004-03-28T00:00:00+00:00</dcterms:W3CDTF>
</rdf:Description>
</rdf:RDF>
</model>
